|
"hsu yc"的相關文件
顯示項目 51-75 / 179 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2019-07 |
Biocompatible and multifunctional gold nanorods for effective photothermal therapy of oral squamous cell carcinoma
|
Liao, YT;Liu, CH;Chin, Y;Chen, SY;Liu, SH;Hsu, YC;Wu, KCW |
| 國家衛生研究院 |
2019-03-18 |
Association of daily aspirin therapy with risk of hepatocellular carcinoma in patients with chronic hepatitis B
|
Lee, TY;Hsu, YC;Tseng, HC;Yu, SH;Lin, JT;Wu, MS;Wu, CY |
| 國家衛生研究院 |
2019-02-09 |
Standing genetic variation as the predominant source for adaptation of a songbird
|
Lai, YT;Yeung, CKL;Omland, KE;Pang, EL;Hao, Y;Liao, BY;Cao, HF;Zhang, BW;Yeh, CF;Hung, CM;Hung, HY;Yang, MY;Liang, W;Hsu, YC;Yao, CT;Dong, L;Lin, K;Li, SH |
| 國家衛生研究院 |
2019-01-08 |
Reply to: "Diabetes mellitus as a risk factor of hepatocellular carcinoma in patients with chronic hepatitis B on nucleot(s)ide analogues"
|
Hsu, YC;Yip, TC;Wong, GL;Wu, CY |
| 國家衛生研究院 |
2019-01-08 |
Development of a scoring system to Predict Hepatocellular Carcinoma in Asians on Antivirals for Chronic Hepatitis B [Erratum:Journal of Hepatology. 2018 Aug;69(2):278-285.]
|
Hsu, YC;Yip, TC;Ho, HJ;Wong, VW;Huang, YT;El-Serag, HB;Lee, TY;Wu, MS;Lin, JT;Wong, GL;Wu, CY |
| 國家衛生研究院 |
2018-10-23 |
Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice
|
Lai, ZL;Tseng, CH;Ho, HJ;Cheung, CKY;Lin, JY;Chen, YJ;Cheng, FC;Hsu, YC;Lin, JT;El-Omar, EM;Wu, CY |
| 臺大學術典藏 |
2018-09-10T07:29:41Z |
Enhanced photovoltaic performance by synergism of light-cultivation and electronic localization for highly efficient dye-sensitized solar cells
|
Lu, KL; Lin, HC; Chen, JG; Ho, KC; Hsu, YC; Bhattacharya, D; Yin, JF; KUO-CHUAN HO et al.; Yin, JF; Yin, Jf; Tsai, CC |
| 臺大學術典藏 |
2018-09-10T07:29:38Z |
Tunable novel cyclopentadithiophene-based copolymers containing various numbers of bithiazole and thienyl units for organic photovoltaic cell applications
|
Lin, HC;Wei, KH;Ho, KC;Lin, JT;Chu, CW;Huang, PJ;Hsu, YC;Huang, JH;KUO-CHUAN HO;Li, KC;Lin, H.-C.;Wei, K.-H.;Ho, K.-C.;Lin, J.-T.;Chu, C.-W.;Huang, P.-J.;Hsu, Y.-C.;Huang, J.-H.;Li, K.-C.;Lin, HC;Wei, KH;Ho, KC;Lin, JT;Chu, CW;Huang, PJ;Hsu, YC;Huang, JH;KUO-CHUAN HO;Li, KC; Li, K.-C.; Huang, J.-H.; Hsu, Y.-C.; Huang, P.-J.; Chu, C.-W.; Lin, J.-T.; Ho, K.-C.; Wei, K.-H.; Lin, H.-C.; Li, KC; KUO-CHUAN HO; Huang, JH; Hsu, YC; Huang, PJ; Chu, CW; Lin, JT; Ho, KC; Wei, KH; Lin, HC |
| 臺大學術典藏 |
2018-09-10T05:16:47Z |
Mechanistic study of apatite formation on bioactive glass surface using P-31 solid-state NMR Spectroscopy
|
Tseng, YH; Mou, Y; Hsu, YC; Yang, CM; Chan, JCC; CHUN-CHUNG CHAN; Lin, KSK; Tseng, YH; Mou, Y; Hsu, YC; Yang, CM; Chan, JCC; Lin, KSK |
| 國家衛生研究院 |
2018-09-06 |
Cell motility facilitated by mono(2-ethylhexyl) phthalate via activation of the AKT-beta-catenin-IL-8 axis in colorectal cancer
|
Luo, CW;Hsiao, IL;Wang, JY;Wu, CC;Hung, WC;Lin, YH;Chen, TY;Hsu, YC;Cheng, TL;Pan, MR |
| 國家衛生研究院 |
2018-07 |
National surveillance of 2,3,7,8-substituted polychlorinated dibenzo-p-dioxins/furans in soil in Taiwan
|
Hsu, YC;Que, DE;Gou, YY;Tsou, TC;Liu, CK;Wang, YL;Hou, WC;Lin, YH;Liu, WY;Chao, HR;Lee, WJ |
| 國家衛生研究院 |
2018-05-25 |
Effect of a point mutation in mprF on susceptibility to daptomycin, vancomycin, and oxacillin in an MRSA clinical strain
|
Chen, FJ;Lauderdale, TL;Lee, CH;Hsu, YC;Huang, IW;Hsu, PC;Yang, CS |
| 國家衛生研究院 |
2018-03-15 |
Development of a scoring system to Predict Hepatocellular Carcinoma in Asians on Antivirals for Chronic Hepatitis B
|
Hsu, YC;Yip, CF;Ho, HJ;Wong, WS;Huang, YT;El-Serag, HB;Lee, TY;Wu, MS;Lin, JT;Wong, GLH;Wu, CY |
| 國家衛生研究院 |
2017-09-22 |
Effect of nucleos(t)ide analogue therapy on risk of intra-hepatic cholangioarcinoma in patients with chronic hepatitis B
|
Lee, TY;Hsu, YC;Yu, SH;Lin, JT;Wu, MS;Wu, CY |
| 國家衛生研究院 |
2017-08 |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Hsu, YC;Mo, LR;Chang, CY;Wu, MS;Yang, TH;Kao, JH;Chen, CC;Tseng, CH;Tai, CM;Lin, CW;Wu, CY;Lin, JT |
| 國家衛生研究院 |
2016-06 |
Activation of Aurora A kinase through the FGF1/FGFR signaling axis sustains the stem cell characteristics of glioblastoma cells
|
Hsu, YC;Kao, CY;Chung, YF;Lee, DC;Liu, JW;Chiu, IM |
| 國家衛生研究院 |
2016-05 |
Estrogenic effects in the influents and effluents of the drinking water treatment plants
|
Gou, YY;Lin, S;Que, DE;Tayo, LL;Lin, DY;Chen, KC;Chen, FA;Chiang, PC;Wang, GS;Hsu, YC;Chuang, KP;Chuang, CY;Tsou, TC;Chao, HR |
| 國家衛生研究院 |
2016-04 |
Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: A nationwide cohort study
|
Wu, CY;Hsu, YC;Ho, HJ;Chen, YJ;Lee, TY;Lin, JT |
| 中國醫藥大學 |
2015-10 |
Saturated fatty acid induces cancer stem cell-like properties in human hepatoma cells
|
(Chong LW);鄒瑞煌(Ruey-Hwang Chou);(Liao CC);(Lee TF);(Lin Y);(Yang KC);(Hsu YC)* |
| 中國醫藥大學 |
2015-10 |
Targeting post-translational modifications of histones for cancer therapy
|
(Hsu YC);(Hsieh YH);(Liao CC);(Chong LW);(Lee CY);余永倫(Yung-Luen Yu)*;鄒瑞煌(Ruey-Hwang Chou)* |
| 輔英科技大學 |
2015-09-01 |
A Large-Scale Study Indicates Increase in the Risk of Epilepsy in Patients With Different Risk Factors, Including Rheumatoid Arthritis
|
Chang KH; Hsu YC; Mei-Yin Chang; Lin CL; Wu TN; Hwang BF; Chen CY; Liu HC;Kao CH; |
| 國家衛生研究院 |
2015-08 |
Optimization of quinazoline-based kinase inhibitors: Identification of a dual FLT3/AURKA kinase inhibitor for the treatment of acute myeloid leukemia
|
Hsieh, HP;Hsu, YC;Ke, YY;Shiao, HY;Chang, CW;Lin, WH;Hsu, TA;Yeh, TK;Chen, CT |
| 國家衛生研究院 |
2015-08 |
Optimization of furanopyrimidine-based kinase inhibitors: Identification of a BTK kinase inhibitor for the treatment of B cell lymphoma
|
Wang, WC;Hsu, YC;Shiao, HY;Hung, HC;Kuo, CC;Lee, JC;Hsu, TA;Hsieh, HP |
| 國家衛生研究院 |
2015-08 |
Discovery of 2,4-diaminopyrimidines bearing a unique pharmacophore as anaplastic lymphoma kinase inhibitors
|
Shiao, HY;Wang, WC;Hsu, YC;Ke, YY;Hsu, TA;Hsieh, HP |
| 國家衛生研究院 |
2015-07 |
R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability
|
Chen, HY;Yu, SL;Ho, BC;Su, KY;Hsu, YC;Chang, CS;Li, YC;Yang, SY;Hsu, PY;Ho, H;Chang, YH;Chen, CY;Yang, HI;Hsu, CP;Yang, TY;Chen, KC;Hsu, KH;Tseng, JS;Hsia, JY;Chuang, CY;Yuan, S;Lee, MH;Liu, CH;Wu, GI;Hsiung, CA;Chen, YM;Wang, CL;Huang, MS;Yu, CJ;Chen, KY;Tsai, YH;Su, WC;Chen, HW;Chen, JJ;Chen, CJ;Chang, GC;Yang, PC;Li, KC |
顯示項目 51-75 / 179 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目
|
